USE OF M-CSF FOR PREVENTING OR TREATING MYELOID CYTOPENIA AND RELATED COMPLICATIONS

Publikation: Geistiges Eigentum › Patentanmeldung/Patent

Beitragende

  • INSERM - Institut national de la santé et de la recherche médicale
  • Centre national de la recherche scientifique (CNRS)
  • Aix-Marseille Université

Abstract

The invention relates to methods and compositions comprising a macrophage colony stimulating factor (M-CSF) polypeptide or an agonist of the M-CSF receptor for preventing or treating myeloid cytopenia and related complications (such as infections) in a patient in need thereof (such as a patient undergoing hematopoietic stem cell transplantation).

Details

The invention relates to methods and compositions comprising a macrophage colony stimulating factor (M-CSF) polypeptide or an agonist of the M-CSF receptor for preventing or treating myeloid cytopenia and related complications (such as infections) in a patient in need thereof (such as a patient undergoing hematopoietic stem cell transplantation).

OriginalspracheEnglisch
IPC (Internationale Patentklassifikation)C12N 5/ 0789 A I
VeröffentlichungsnummerUS2016045567
Land/GebietDeutschland
Prioritätsdatum9 Apr. 2014
PrioritätsnummerWO2014EP57191
PublikationsstatusVeröffentlicht - 18 Feb. 2016
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.Patent